- Toxicity, costs must be considered when using chemotherapy-immunotherapy combinations for lung cancer – Healio
- PD-L1 Status Central to NCCN Update for Frontline NSCLC Immunotherapy – OncLive
- Immunotherapy likely to become standard for recurrent/metastatic head and neck cancers – Healio
- Skin Cancer Risk Reduced by Topical Immunotherapy – Genetic Engineering & Biotechnology News
- Immunotherapy of precancerous skin lesions may prevent squamous cell carcinoma: Risk of skin cancer development cut almost 75 percent in clinical trial participants who received immunotherapy treatment – Science Daily
- Dr. Slovin Discusses History of Immunotherapy in Prostate Cancer – OncLive
- Topical Immunotherapy Lowers Risk of Skin Cancer – Technology Networks
